COVID-19: A Study to Evaluate Safety, Reactogenicity and Immunogenicity of the SARS-CoV-2 mRNA Vaccine CVnCoV in Adults With Co-morbidities

Name: COVID-19: A Study to Evaluate Safety, Reactogenicity and Immunogenicity of the SARS-CoV-2 mRNA Vaccine CVnCoV in Adults With Co-morbidities
Published: 2021
License: Public Domain

CureVac · 2021

ClinicalTrials.gov · Datasets · License: Public Domain · 2021

Open Source ↗

coronavirus cov covid19 immunogenicity safety sars vaccine

coronavirus, covid19, sars-cov-2, severe acute respiratory syndrome, cvncov, sars-cov-2 mrna vaccine, vaccine, sars, covid, safety, reactogenicity, immunogenicity

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 831341
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.